Skip to content
Back to Investors
Angel CoFund

Angel CoFund

Venture Capital

An investment fund backed by the British Business Bank.

Portfolio

27

companies

AUM

£40.0M

under management

By category

  • FoodTech£18.0M
  • FinTech£13.6M
  • HealthTech£12.2M
  • AgriTech£7.0M
  • AI/ML£5.5M
  • Other£24.1M

By location

  • United Kingdom£26.4M
  • London£24.0M
  • Northern Ireland£11.9M
  • Huddersfield£3.0M
  • Oxford£2.2M
  • Other£12.9M

Portfolio companies

4M

4040 Media

4040 Media produces animated explainer videos to help businesses increase sales and productivity.

AM

Albert Medical Devices

Albert Medical Devices develops intelligent urology products including the melio catheter leg bag.

B

Bactest

Bactest develops microbial testing instruments and sludge management systems for water and industrial applications.

BrainWaveBank

BrainWaveBank

BrainWaveBank develops a digital platform for remote monitoring of neurological and psychiatric conditions.

CF

Contego Fraud Solutions

Contego Fraud Solutions develops risk management software for due diligence and compliance analysis.

DPL

DPL

DPL builds a platform that combines artificial intelligence and behavioural science to automate and improve marketing effectiveness.

View all 27 companies
DT

Dogtooth Technologies

Dogtooth Technologies builds autonomous fruit-picking robots for agriculture.

F

Form3

Form3 provides cloud-based payment processing infrastructure for financial institutions.

G

Gousto

Gousto provides a meal kit delivery service for home cooking.

HR DataHub

HR DataHub

HR DataHub operates a data benchmarking platform that helps organisations inform their employment policies.

ID

IMSPEX Diagnostics

IMSPEX Diagnostics develops analytical chemistry devices for monitoring and quality control applications.

K

Keit

Keit manufactures robust spectrometer technology for industrial process monitoring.

L

Limejump

Limejump uses real-time data to manage commercial electricity supplies and demand-side response programmes.

Micrima

Micrima

Micrima develops radio-wave breast imaging technology for clinical use.

N

Neurovalens

Neurovalens creates wearable devices that stimulate the brain to address metabolic and health issues.

Nivo

Nivo

Secure instant messaging and identity verification platform for financial services.

O

OTCX

OTCX provides a digital platform for trading over-the-counter derivatives.

O

Ownfone

Ownfone provides customisable and accessible mobile handsets for users who find standard devices difficult to operate.

Oxford Drug Design

Oxford Drug Design

Oxford Drug Design develops novel cancer therapeutics using a proprietary computational and machine learning platform.

Scoota

Scoota

Scoota provides automated omni-channel digital branding and fraud prevention technology.

SP

Small Pharma

Small Pharma develops rapid-acting antidepressant treatments for severe depression.

SP

Smile Plastics

Smile Plastics manufactures decorative panels from fully recycled materials for retail and hospitality interiors.

S

Sophia

Sophia operates an advertising platform that uses artificial intelligence to make digital ads more relevant.

Spotta

Spotta

Spotta creates connected monitoring devices for insect pest management across various industries.

VP

Vantage Power

Vantage Power develops hybrid electric powertrains and telematics software for buses.

Wayland Additive

Wayland Additive

Wayland Additive develops advanced electron beam 3D printing systems for industrial manufacturing.

a

autologyx

Autologyx builds a digital operations platform that automates complex business processes.


Team

TM

Tim Mills

Investment Director

LinkedIn
GW

George Whitehead

Partner

George is a partner at ACF Investors and chairs the Clean Growth Fund, having previously cofounded the Venture Capital Trust Association. His career includes investment and board roles with Angel CoFund, Octopus Ventures, and the UK Business Angels Association.

LinkedIn

Recent investments

£980K

The funding round was led by Green Angel Syndicate to support production scale up and team expansion.

"This investment is well timed to enable us to realise the rapid growth needed to meet the demand for our product in the UK and internationally."
— Rosalie McMillan, Founding Director
Series A
£1.9M

The funding round was led by Technology Venture Partners alongside government backing to support the commercialisation of a new breast scanning system.

"this investment will allow us to move the company into the next phase with a system that has a place in a clinical workflow and more exciting functionality to come as soon as clinical data collection can re commence"
— Nick Randall, Chairman
Seed
£1.0M

The funding round was led by the Angel CoFund alongside a syndicate of experienced angel investors.

"Our vision is for any size company, in any sector, to have access to business-critical HR data. We aim to help all clients navigate some of the most difficult employment issues that they are facing today. Our experience has shown us that companies are ready and willing to address HR issues within their businesses, they just need to be armed with the insights to do it. Our platform can be instantly transformative to clients, as well as delivering material cost savings to businesses of all sizes. We are delighted to have such a strong, experienced and engaged syndicate of angel investors, as well as the Angel CoFund on board to help us capitalise on the huge growth we are seeing."
— David Whitfield, MD
Seed
£934K

Cambridge Angels and REMUS led the seed round to support international expansion and product development.

"For decades, pest management has been held back by laborious, error-prone manual monitoring. With our technology it is finally possible to change this and help industries around the world to make a step change from reactive to proactive management of pests. This will save billions and massively reduce the amount of pesticide used globally. We’re delighted to have strong support from a wide group of investors who share our vision. This funding will allow us to scale up our commercial operations and continue to address the £320bn global problem of insect pests."
— Robert Fryers, Co-founder and CEO